This past week, South Africa’s Department of Health removed Cannabidiol from the country’s Schedule 7 list of highly controlled drugs, allowing for legal sale of CBD products made in accordance with the government’s specified preparations.
Supreme Cannabis’ international medical cannabis oil partner, Medigrow Lesotho, is licensed by the Lesotho Ministry of Health to cultivate and manufacture medical cannabis and cannabis oil products in the Kingdom of Lesotho, a jurisdiction located within Southern Africa. "Supreme Cannabis will explore opportunities to serve South Africa’s commercial CBD market through its preferential global distribution agreement with Medigrow," the team with the company explains.
“This meaningful change to South Africa’s legislation creates immense opportunity for Medigrow to manufacture and supply high-quality CBD oil to a neighbouring jurisdiction,” said Navdeep Dhaliwal, CEO of Supreme Cannabis. “We are pleased to see countries like South Africa adopting thoughtful changes to policy and implementing well-regulated systems with the potential to improve public health and wellness.”
According to them, Medigrow’s advanced commercial operations include a rapidly-scaling cultivation facility being built to EU GMP standards and an industrial-grade oil extractor. In anticipation of its first international exports, Medigrow is currently building an inventory of oils.